Skip to main content

George Lasezkay

Equibles does not estimate personal net worth.

About George Lasezkay

Earlier roles on record: CEO at Clearside Biomedical, Inc. (CLSDQ) until July 18, 2025. Clearside Biomedical, Inc. reported in an 8-K filed July 17, 2025 that George Lasezkay was terminated as President and Chief Executive Officer, effective July 18, 2025. The proxy statement of Clearside Biomedical, Inc. reports total compensation of $1,538,627 for George Lasezkay in fiscal 2023, including a base salary of $547,200. Disclosed compensation is on record for 5 fiscal years.

“In connection with the workforce reduction, each of George Lasezkay, the Company's President and Chief Executive Officer, Charles A. Deignan, the Company's Chief Financial Officer, and Victor Chong, the Company's Chief Medical Officer plan to enter into a Separation Agreement with the Company (collectively, the "Separation Agreements"), pursuant to which each executive's employment with the Company will cease effective as of July 18, 2025 (the "Separation Date").”
Clearside Biomedical, Inc. Form 8-K, filed July 17, 2025 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Clearside Biomedical, Inc. (CLSDQ) $547,200 $1,538,627
2022 Clearside Biomedical, Inc. (CLSDQ) $531,500 $1,531,215
2021 Clearside Biomedical, Inc. (CLSDQ) $516,000 $2,340,969
2020 Clearside Biomedical, Inc. (CLSDQ) $503,313 $1,371,007
2019 Clearside Biomedical, Inc. (CLSDQ) $371,235 $1,045,192

Recent activity